Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients

被引:34
作者
Ishiyama, Masami [1 ]
Suzuki, Eiji [1 ,2 ]
Katsuda, Jun [1 ]
Murase, Hiroshi [1 ]
Tajima, Yoshitaka [1 ]
Horikawa, Yukio [1 ]
Goto, Shinobu [3 ]
Fujita, Tamio [3 ]
Takeda, Jun [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Endocrinol & Diabet, Gifu 5011194, Japan
[2] Gifu Prefectural Gen Med Ctr, Dept Internal Med, Gifu 5008717, Japan
[3] Nagoya Mem Hosp, Dept Internal Med, Tenpaku Ku, Nagoya, Aichi 4688520, Japan
关键词
Coronary artery calcification; Carotid intima-media thickness; Bone-related peptide; Type; 2; diabetes; BEAM COMPUTED-TOMOGRAPHY; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; OSTEOPONTIN LEVELS; OSTEOPROTEGERIN LEVELS; RECEPTOR ACTIVATOR; ENDOTHELIAL-CELLS; DISEASE; PROGRESSION;
D O I
10.1016/j.diabres.2009.04.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular calcification is frequently accompanied by intima-media thickening, but the associations among these atherosclerotic features and bone-related peptides in diabetic patients are unclear. We enrolled 168 type 2 diabetic patients and 40 non-diabetic subjects consecutively admitted to our hospital. Mean intima-media thickness (mean-IMT) in common carotid arteries was measured by B-mode ultrasonography. Agatston coronary artery calcium score (CACS) was obtained using multidetector-row computed tomography (MDCT). Plasma bone-related peptides osteopontin and osteoprotegerin levels were measured. Diabetic patients had higher mean-IMT (p = 0.0002) and log(CACS + 1) (p < 0.0001) and similar bone-related peptides compared to non-diabetic subjects. in diabetic patients classified into tertiles according to their CACS levels, those with the highest scores showed the highest mean-IMT (p = 0.0004) and bone-related peptides (p < 0.05) among the groups. log(CACS + 1) and mean-IMT were associated (p < 0.0001) and were positively correlated with osteopontin (p < 0.01) and osteoprotegerin (p < 0.01) in diabetic patients. Multivariate analyses revealed that the significant independent determinants of log(CACS + 1) were age, duration of diabetes and osteopontin (p < 0.0001) and those of mean-IMT were age, hypertension, osteopontin and osteoprotegerin (p < 0.0001), respectively. We have demonstrated that vascular calcification in type 2 diabetic patients is frequently accompanied by intimamedia thickening, and osteopontin may act as a vascular calcification inhibitor by increasing intima-media thickness. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 46 条
[1]   Influence of lipid-lowering therapy on the progression of coronary artery calcification - A prospective evaluation [J].
Achenbach, S ;
Ropers, D ;
Pohle, K ;
Leber, A ;
Thilo, C ;
Knez, A ;
Menendez, T ;
Maeffert, R ;
Kusus, M ;
Regenfus, M ;
Bickel, A ;
Haberl, R ;
Steinbeck, G ;
Moshage, W ;
Daniel, WG .
CIRCULATION, 2002, 106 (09) :1077-1082
[2]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[6]   The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects [J].
Anand, DV ;
Lahiri, A ;
Lim, E ;
Hopkins, D ;
Corder, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) :1850-1857
[7]  
[Anonymous], 2002, American Journal of Kidney Disease, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943
[8]   Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients [J].
Avignon, A ;
Sultan, A ;
Piot, C ;
Elaerts, S ;
Cristol, JP ;
Dupuy, AM .
DIABETES CARE, 2005, 28 (09) :2176-2180
[9]   Diabetic neuropathies - A statement by the American Diabetes Association [J].
Boulton, AJM ;
Vinik, AI ;
Arezzo, JC ;
Bril, V ;
Feldman, EL ;
Freeman, R ;
Malik, RA ;
Maser, RE ;
Sosenko, JM ;
Ziegler, D .
DIABETES CARE, 2005, 28 (04) :956-962
[10]   Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis [J].
Collin-Osdoby, P ;
Rothe, L ;
Anderson, F ;
Nelson, M ;
Maloney, W ;
Osdoby, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20659-20672